Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Caulfield

Showing results (21-30 of 91) with videos related to

Pageof 10
Sort By:
BMJ Open|August 9, 2015
Comparison of single and combination diuretics on glucose tolerance (PATHWAY-3): protocol for a randomised double-blind trial in patients with essential hypertensionMorris J Brown, Bryan Williams, Thomas M MacDonald, et al.
BMJ Open|August 9, 2015
Prevention And Treatment of Hypertension With Algorithm-based therapy (PATHWAY) number 2: protocol for a randomised crossover trial to determine optimal treatment for drug-resistant hypertensionBryan Williams, Thomas M MacDonald, Mark Caulfield, et al.
Lancet (London, England)|August 27, 2011
Cost-effectiveness of options for the diagnosis of high blood pressure in primary care: a modelling studyKate Lovibond, Sue Jowett, Pelham Barton, et al.
European Heart Journal|December 6, 2006
Potential synergy between lipid-lowering and blood-pressure-lowering in the Anglo-Scandinavian Cardiac Outcomes TrialPeter Sever, Björn Dahlöf, Neil Poulter, et al.
International Journal of Environmental Research and Public Health|February 15, 2022
Factors Affecting Citizen Trust and Public Engagement Relating to the Generation and Use of Real-World Evidence in HealthcareDenis Horgan, Bettina Borisch, Ivana Cattaneo, et al.
Hypertension (Dallas, Tex. : 1979)|January 5, 2006
Chromosome 2p shows significant linkage to antihypertensive response in the British Genetics of Hypertension StudySandosh Padmanabhan, Chris Wallace, Patricia B Munroe, et al.
BMJ Open|August 9, 2015
Monotherapy versus dual therapy for the initial treatment of hypertension (PATHWAY-1): a randomised double-blind controlled trialThomas M MacDonald, Bryan Williams, Mark Caulfield, et al.
Diabetes Care|April 28, 2005
Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes: Anglo-Scandinavian Cardiac Outcomes Trial--lipid-lowering arm (ASCOT-LLA)Peter S Sever, Neil R Poulter, Björn Dahlöf, et al.
Journal of Hypertension|October 16, 2008
The Anglo-Scandinavian Cardiac Outcomes Trial: blood pressure-lowering limb: effects in patients with type II diabetesJan Ostergren, Neil R Poulter, Peter S Sever, et al.
Lancet (London, England)|April 11, 2003
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trialPeter S Sever, Björn Dahlöf, Neil R Poulter, et al.
Pageof 10

Showing results (21-30 of 91) with videos related to

Sort By:
Pageof 10
BMJ Open|August 9, 2015
Comparison of single and combination diuretics on glucose tolerance (PATHWAY-3): protocol for a randomised double-blind trial in patients with essential hypertensionMorris J Brown, Bryan Williams, Thomas M MacDonald, et al.
BMJ Open|August 9, 2015
Prevention And Treatment of Hypertension With Algorithm-based therapy (PATHWAY) number 2: protocol for a randomised crossover trial to determine optimal treatment for drug-resistant hypertensionBryan Williams, Thomas M MacDonald, Mark Caulfield, et al.
Lancet (London, England)|August 27, 2011
Cost-effectiveness of options for the diagnosis of high blood pressure in primary care: a modelling studyKate Lovibond, Sue Jowett, Pelham Barton, et al.
European Heart Journal|December 6, 2006
Potential synergy between lipid-lowering and blood-pressure-lowering in the Anglo-Scandinavian Cardiac Outcomes TrialPeter Sever, Björn Dahlöf, Neil Poulter, et al.
International Journal of Environmental Research and Public Health|February 15, 2022
Factors Affecting Citizen Trust and Public Engagement Relating to the Generation and Use of Real-World Evidence in HealthcareDenis Horgan, Bettina Borisch, Ivana Cattaneo, et al.
Hypertension (Dallas, Tex. : 1979)|January 5, 2006
Chromosome 2p shows significant linkage to antihypertensive response in the British Genetics of Hypertension StudySandosh Padmanabhan, Chris Wallace, Patricia B Munroe, et al.
BMJ Open|August 9, 2015
Monotherapy versus dual therapy for the initial treatment of hypertension (PATHWAY-1): a randomised double-blind controlled trialThomas M MacDonald, Bryan Williams, Mark Caulfield, et al.
Diabetes Care|April 28, 2005
Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes: Anglo-Scandinavian Cardiac Outcomes Trial--lipid-lowering arm (ASCOT-LLA)Peter S Sever, Neil R Poulter, Björn Dahlöf, et al.
Journal of Hypertension|October 16, 2008
The Anglo-Scandinavian Cardiac Outcomes Trial: blood pressure-lowering limb: effects in patients with type II diabetesJan Ostergren, Neil R Poulter, Peter S Sever, et al.
Lancet (London, England)|April 11, 2003
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trialPeter S Sever, Björn Dahlöf, Neil R Poulter, et al.
Pageof 10